 RAMSEY, N.J. and BOCA RATON, Fla., Oct. 18, 2021 GLOBE NEWSWIRE -- ADMA Biologics, Inc. Nasdaq: ADMA ADMA or the Company, an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced the appointment of Young T. Kwon, Ph.D., to its Board of Directors. Dr. Kwon is a highly accomplished corporate executive in the life sciences and biotechnology space. He brings over a decade of expertise in strategic advising, corporate finance and business development transactions to ADMAs Board. 